It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMPH’s FA Score shows that 0 FA rating(s) are green whileHKMPF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMPH’s TA Score shows that 1 TA indicator(s) are bullish while HKMPF’s TA Score has 5 bullish TA indicator(s).
AMPH (@Pharmaceuticals: Other) experienced а -1.82% price change this week, while HKMPF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.
AMPH is expected to report earnings on May 08, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
AMPH | HKMPF | AMPH / HKMPF | |
Capitalization | 2.11B | 5.93B | 36% |
EBITDA | 240M | 489M | 49% |
Gain YTD | -3.851 | 1.949 | -198% |
P/E Ratio | 16.69 | 31.65 | 53% |
Revenue | 644M | 2.52B | 26% |
Total Cash | 257M | 292M | 88% |
Total Debt | 624M | 1.28B | 49% |
AMPH | HKMPF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | 17 Undervalued | |
PROFIT vs RISK RATING 1..100 | 51 | 100 | |
SMR RATING 1..100 | 40 | 92 | |
PRICE GROWTH RATING 1..100 | 87 | 51 | |
P/E GROWTH RATING 1..100 | 94 | 55 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HKMPF's Valuation (17) in the null industry is somewhat better than the same rating for AMPH (67) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew somewhat faster than AMPH’s over the last 12 months.
AMPH's Profit vs Risk Rating (51) in the Pharmaceuticals Other industry is somewhat better than the same rating for HKMPF (100) in the null industry. This means that AMPH’s stock grew somewhat faster than HKMPF’s over the last 12 months.
AMPH's SMR Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for HKMPF (92) in the null industry. This means that AMPH’s stock grew somewhat faster than HKMPF’s over the last 12 months.
HKMPF's Price Growth Rating (51) in the null industry is somewhat better than the same rating for AMPH (87) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew somewhat faster than AMPH’s over the last 12 months.
HKMPF's P/E Growth Rating (55) in the null industry is somewhat better than the same rating for AMPH (94) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew somewhat faster than AMPH’s over the last 12 months.
AMPH | HKMPF | |
---|---|---|
RSI ODDS (%) | 11 days ago81% | 11 days ago32% |
Stochastic ODDS (%) | N/A | 11 days ago38% |
Momentum ODDS (%) | N/A | 11 days ago52% |
MACD ODDS (%) | N/A | 11 days ago35% |
TrendWeek ODDS (%) | 11 days ago68% | 11 days ago39% |
TrendMonth ODDS (%) | 11 days ago65% | 11 days ago43% |
Advances ODDS (%) | N/A | N/A |
Declines ODDS (%) | 12 days ago67% | N/A |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 11 days ago60% | 11 days ago62% |
A.I.dvisor tells us that AMPH and AMRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMPH and AMRX's prices will move in lockstep.
Ticker / NAME | Correlation To AMPH | 1D Price Change % | ||
---|---|---|---|---|
AMPH | 100% | +0.11% | ||
AMRX - AMPH | 32% Poorly correlated | -0.60% | ||
EOLS - AMPH | 28% Poorly correlated | -0.94% | ||
VTRS - AMPH | 28% Poorly correlated | -0.35% | ||
HROW - AMPH | 28% Poorly correlated | +1.17% | ||
DVAX - AMPH | 27% Poorly correlated | +0.48% | ||
More |
A.I.dvisor tells us that HKMPF and AMPH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPF and AMPH's prices will move in lockstep.
Ticker / NAME | Correlation To HKMPF | 1D Price Change % | ||
---|---|---|---|---|
HKMPF | 100% | N/A | ||
AMPH - HKMPF | 24% Poorly correlated | +0.11% | ||
CAIHF - HKMPF | 24% Poorly correlated | N/A | ||
HLTRF - HKMPF | 11% Poorly correlated | N/A | ||
GRUSF - HKMPF | 9% Poorly correlated | -0.06% | ||
ESALF - HKMPF | 7% Poorly correlated | +2.50% | ||
More |